ILC3s regulate epithelial glycosylation. Commensal bacteria, including segmented f lamentous bacteria (SFB), induce IL-22 production by ILC3. LT is produced by ILC3 in a commensal bacteria-independent manner. ILC3-derived IL-22 and LT cooperatively induce the production of Fut2 and subsequent epithelial fucosylation, which protects the host against Salmonella typhimurium infection. Bacteroides thetaiotaomicron induce epithelial fucosylation, how mucosal immune cells participate in this process is unknown. We used a combination of bacteriological, gnotobiological, and immunological techniques to elucidate the cellular and molecular basis of epithelial fucosylation by mucosal immune cells in mice, especially innate lymphoid cells (ILCs). To explore the role of ILCs in the induction and maintenance of epithelial fucosylation, we used genetically engineered mice lacking genes associated with the development and function of ILCs. To investigate the physiological functions of ILC-induced epithelial fucosylation, we used a Fut2-deficient mouse model of S. typhimurium infection.
RESEARCH ARTICLE SUMMARY
ILC3s regulate epithelial glycosylation. Commensal bacteria, including segmented f lamentous bacteria (SFB), induce IL-22 production by ILC3. LT is produced by ILC3 in a commensal bacteria-independent manner. ILC3-derived IL-22 and LT cooperatively induce the production of Fut2 and subsequent epithelial fucosylation, which protects the host against Salmonella typhimurium infection. Bacteroides thetaiotaomicron induce epithelial fucosylation, how mucosal immune cells participate in this process is unknown. We used a combination of bacteriological, gnotobiological, and immunological techniques to elucidate the cellular and molecular basis of epithelial fucosylation by mucosal immune cells in mice, especially innate lymphoid cells (ILCs). To explore the role of ILCs in the induction and maintenance of epithelial fucosylation, we used genetically engineered mice lacking genes associated with the development and function of ILCs. To investigate the physiological functions of ILC-induced epithelial fucosylation, we used a Fut2-deficient mouse model of S. typhimurium infection.
RESULTS:
The induction and maintenance of Fut2 expression and subsequent epithelial fucosylation in the GI tract required type 3 ILCs (ILC3s) that express the transcription factor RORγt and the cytokines interleukin-22 (IL-22) and lymphotoxin (LT).
Commensal bacteria, including segmented filamentous bacteria (SFB), induced fucosylation of intestinal columnar ECs and goblet cells. Expression of IL-22 by ILC3 required commensal bacteria, whereas LT was expressed in a commensal-independent manner. Ablation of IL-22 or LT in ILC3 resulted in a marked reduction in epithelial fucosylation, demonstrating that both cytokines are critical for the induction and regulation of epithelial fucosylation. Fucosylation of ECs in response to the intestinal pathogen S. typhimurium was also mediated by ILC3. Compared with control mice, Fut2-deficient mice were more susceptible to pathogenic inflammation as a result of S. typhimurium infection, suggesting that epithelial fucosylation contributes to host defense against S. typhimurium infection.
INTRODUCTION:
The combination of food intake and the resident gut microbiota exposes the gastrointestinal (GI) tract to numerous antigens. Intestinal epithelial cells (ECs) compose a physical barrier separating the internal organs from the gut microbiota and other pathogenic microorganisms entering the GI tract. Although anatomically contained, the gut microbiota is essential for developing appropriate host immunity. Thus, the mucosal immune system must simultaneously maintain homeostasis with the gut microbiota and protect against infection by pathogens. Maintenance of the gut microbiota requires epithelial cellsurface glycosylation, with fucose residues in particular. Epithelial fucosylation is mediated by the enzyme fucosyltransferase 2 (Fut2). Polymorphisms in the FUT2 gene are associated with the onset of multiple infectious and inflammatory diseases and metabolic syndrome in humans.
RATIONALE: Despite its importance, the mechanisms underlying epithelial fucosylation in the GI tract is not well understood. In particular, although commensals such as I n the gastrointestinal tract, bilateral regulation between the gut microbiota and the host creates a mutually beneficial environment. The intestinal epithelium is a physical barrier that separates the environments inside and outside the mucosal surface. Intestinal epithelial cells (ECs) are the first line of defense against foreign antigens, including those from commensal and pathogenic bacteria. ECs play key roles in initiating and maintaining an immunologically appropriate and balanced environment in reaction to constant foreign stimulation (1) . Resident commensal bacteria support the development of this functional mucosal immune system, and in turn, mucosal immune cells control the homeostasis of the gut microbiota and protect against pathogenic bacterial infection through intestinal ECs. In particular, type 3 innate lymphoid cells (ILC3) produce interleukin-22 (IL-22), which not only regulates the homeostasis of the commensal microbiota but also protects against Citrobacter rodentium infection, presumably by inducing EC-derived antimicrobial molecules such as RegIIIg (2) (3) (4) (5) .
Fucosylated carbohydrate moieties expressed on intestinal ECs are involved in the creation of an environmental niche for commensal bacteria in mice and humans (6) (7) (8) (9) (10) . Fucosylated glycans are generated by the addition of an L-fucose residue via an a1-2 linkage to the terminal b-D-galactose residues of glycan in a process catalyzed by fucosyltransferase. Two fucosyltransferases, Fut1 and Fut2, mediate intestinal epithelial fucosylation, and each enzyme acts on a distinct subset of epithelial cells. Fut1 regulates fucosylation of Peyer's patch (PP) M cells, whereas Fut2 is a key enzyme regulating intestinal columnar epithelial fucosylation and the production of secretory fucosylated ABO(H) histo-blood group antigens (11). Defective Fut2 has been shown to result in susceptibility to Candida albicans infection in mice (12) . In addition, inactivating polymorphisms of FUT2 are associated with metabolic abnormalities and infectious and inflammatory diseases in humans (13) (14) (15) (16) (17) (18) (19) .
The importance of epithelial fucose has been explored through studies of host-microbe interactions. Signals from commensal bacteria are required for epithelial fucosylation (6) . Specific commensals, in particular Bacteroides, have been shown to induce epithelial fucosylation and are able to catabolize fucose for energy or incorporate it into bacterial cellular componentscapsular polysaccharides-that give microbes a survival advantage in competitive environments (8, 9) . Indeed, a lack of Fut2 alters the diversity and composition of the fecal microbiota in humans and mice (20, 21) . Therefore, epithelial fucose functions as a mediator between the host and commensal microbiota. Although a previous report proposed a model in which Bacteroides-EC interaction mediates epithelial fucosylation (7), the precise mechanisms by which Fut2 regulates fucosylation remain largely unknown.
Microbiota induces epithelial fucosylation
Epithelial fucosylation, a major glycosylation process, occurs in the small intestine (10, 11) . To assess the inductive mechanism of intestinal epithelial fucosylation, we first investigated the localization of fucosylated ECs (F-ECs) along the length of the small intestine, divided equally into four parts from the duodenum (part 1) to the terminal ileum (part 4), in naïve mice (Fig. 1A) . The frequency of F-ECs, detected with the a(1,2)-fucoserecognizing lectin Ulex europaeus agglutinin-1 (UEA-1), was low in the duodenum and jejunum (part 1 and a portion of part 2; <15% F-ECs) and gradually increased toward the ileum (part 4; 40 to 90% F-ECs) (Fig. 1 , A to C). Consistent with epithelial fucosylation, epithelial Fut2 expression was also higher in the ileum (Fig. 1D) . Because greater numbers of microorganisms are present in the distal ileum than in the duodenum (22) , it may be possible that high numbers of ileal F-ECs are induced and maintained through microbial stimulation. To test this hypothesis, we examined the fucosylation status of ileal ECs (part 4) in mice treated with a mixture of antibiotics (AB), as well as in germ-free (GF) mice. The number of F-ECs was dramatically reduced in AB-treated and GF mice ( Fig. 2A and  fig. S1A ). Furthermore, expression of epithelial Fut2 was also reduced in AB-treated mice (Fig.  2B ). Epithelial fucosylation was restored after cessation of AB treatment and in conventionalized GF mice ( Fig. 2A and fig. S1A ). In addition, fucosylation of goblet cells, but not Paneth cells, was lost in AB-treated and GF mice (Fig. 2C) , indicating that commensal bacteria induce fucosylation of columnar epithelial cells and goblet cells, but not Paneth cells.
It has been shown that epithelial fucosylation can be induced by the mouse and human commensal Bacteroides thetaiotaomicron (6) . However, on the basis of bacterial 16S ribosomal RNA (rRNA) gene clone library data obtained from isolated ileal mucus samples from naïve mice (Fig.  2D) , we did not detect B. thetaiotaomicron in our colony, suggesting that other commensals can induce epithelial fucosylation. To identify which indigenous bacteria are responsible for the induction of F-ECs, we analyzed mucus-associated bacterial populations residing in the mouse duodenum (part 1) and ileum (part 4). In contrast to the predominance of Lactobacillus in the duodenum, segmented filamentous bacteria (SFB) predominated in the ileum (Fig. 2D) ; this is consistent with previous studies (23, 24) . SFB are Gram-positive bacteria that preferentially colonize the epithelial surface of the terminal ileum, where they induce T helper 17 (T H 17) cells (25, 26) . Similar to their effect on T H 17 cell-inducing microbiota (27) , vancomycin, ampicillin, and to some extent metronidazole-but not neomycinextinguished epithelial fucosylation ( fig. S1 , B and C). Furthermore, consistent with the emergence of SFB, epithelial fucosylation is initiated after weaning (6, 28) . To investigate whether SFB have the potential to induce F-ECs, we examined mono-associated gnotobiotic mice and found that F-ECs were induced in SFB but not in Lactobacillus murinus mono-associated mice (Fig. 2E) . Together, these results suggest that epithelial fucosylation in the terminal ileum is induced by commensal bacteria, including SFB, under physiological conditions.
ILC3 are required for epithelial fucosylation
We next investigated the cellular and molecular mechanisms of F-EC induction. Commensal bacteria, including SFB, induce the proliferation of intraepithelial lymphocytes and immunoglobulin A (IgA)-producing cells and the development of T H 17 cells; they also modulate the function of ILCs (3, 4, (25) (26) (27) 29) . To assess whether epithelial fucosylation is induced directly by commensal bacteria or is mediated by mucosal immune cells, we first analyzed the epithelial fucose status of T cell-, B cell-, and Ragdeficient mice. The number of F-ECs was not decreased in T cell-or B cell-deficient mice ( fig.  S2 ), indicating that T cells and B cells are dispensable for the induction of epithelial fucosylation. Although SFB induce T H 17 cells (25, 26) , T H 17 cells are not required for epithelial fucosylation because IL-6, a critical cytokine for T H 17 cell differentiation in the intestine (30), was also not necessary for the induction of F-ECs ( fig. S3 , A to C). We next analyzed RAR-related orphan receptor-gt (RORgt)-deficient mice, which lack the ILC3 subset, in addition to T H 17 cells (30, 31) . RORgt-deficient mice exhibited a marked decrease in the number of F-ECs, accompanied by a decrease in Fut2 expression in ileal ECs (Fig.  3, A to D) . These findings suggest that ILC3 are critical inducers of F-ECs. This was further supported by our observation of few F-ECs in the ileum of Id2-deficient mice, which do not develop any of the ILC subsets (Fig. 3 , E to G) (31, 32) . Although both RORgt-and Id2-deficient mice lack PPs (33, 34), PPs are not necessary for epithelial fucosylation because PP-null mice, generated by treatment with monoclonal antibody (mAb) to IL-7R during fetal growth, had normal levels of F-ECs ( fig. S4 ). ILC3 in the small intestine are aberrantly expanded in Rag-deficient mice (35) , and elevated numbers of F-ECs were observed in these mice (Fig. 3 , H and I), supporting the notion that F-ECs are induced by ILC3. Because ILC3 express higher levels of CD90, they can be depleted with a mAb to CD90 (36, 37) . To identify whether ILC3 induce F-ECs, we treated wild-type and Rag-deficient mice with a mAb to CD90. Fut2 expression and the number of F-ECs were markedly decreased after depletion of ILCs in both wild-type and Rag-deficient mice ( 
IL-22 produced by ILC3 mediates epithelial fucosylation
We next investigated how ILC3 induce epithelial fucosylation. ILC3 cells secrete IL-22, which stimulates the antimicrobial function and maintenance of intestinal ECs (3, 4, 36, 38 ILC3 ( fig. S7 , B and C), expression of lL-22 was significantly reduced in AB-treated mice but was restored after cessation of AB treatment ( fig.  S7D ). To identify whether IL-22 is involved in the induction of F-ECs, we analyzed mice lacking IL-22 and found that they had reduced numbers of F-ECs; this was correlated with a decrease in epithelial Fut2 expression (Fig. 4, A and B) . We next examined whether IL-22 alone induced epithelial fucosylation. We used hydrodynamic delivery of an Il22-encoding plasmid vector so as to ectopically overexpress IL-22 in AB-treated mice ( fig. S8, A and B) . In both AB-treated wild-type and Rorc gfp/gfp mice, F-ECs were induced in both the duodenum (part 1) and the ileum (part 4) in mice ectopically producing IL-22 but not in mice receiving control vector (Fig. 4, C and D,  and fig. S8, C and D) . This suggests that IL-22 is sufficient for epithelial fucosylation. Expression of Fut2 was correlated with the presence of IL-22-induced F-ECs (Fig. 4E) . To confirm whether IL-22 produced by ILC3 is necessary for epithelial fucosylation, Rag-deficient mice were treated with an antibody in order to neutralize IL-22. Epithelial Fut2 expression and fucosylation were interrupted by the neutralization of IL-22 ( antibody-to-IL-22-treated Rag-deficient mice revealed the presence of SFB (fig. S6, A and B ). (Fig. 5, F to H) . When the microbiota of LTa-deficient mice or of mixed BM chimeras containing LTa-deficient ILC3 were examined, substantial numbers of SFB were observed ( fig. S6,  A and B) . From these results, we concluded that induction and maintenance of F-ECs were also regulated by ILC3-derived LT in a commensal flora-independent manner.
Epithelial fucosylation protects against infection by Salmonella typhimurium
We next investigated the physiological role of epithelial fucosylation. With exception of Paneth cells, the Fut2 expression and ileal epithelial fucosylation observed in wild-type mice were abolished in Fut2 −/− mice (fig. S11, A to E). We did not detect any overt changes in mucosal leukocyte populations or in IL-22 or LT expression in ILC3 in these mice ( fig. S11F and table S1). Epithelial fucosylation provides an environmental platform for colonization by Bacteroides species (6-9); however, it is unknown whether epithelial fucosylation affects colonization and subsequent infection by pathogenic bacteria. To assess the effects of intestinal fucosylation on pathogenic bacterial infection, we first infected GF mice with the enteropathogenic bacterium Salmonella typhimurium, which has the potential to attach to fucose-containing carbohydrate molecules (42) . After infection with S. typhimurium, ECs from both part 1 (duodenum) and part 4 (ileum) of the mouse intestine were fucosylated, and this was correlated with Fut2 expression (Fig. 6, A and B) . Previous reports have shown that expression of IL-22 in ILCs is much higher in mice infected with S. typhimurium (43, 44).
Therefore, S. typhimurium-induced epithelial fucosylation may be mediated by ILC3. Indeed, epithelial fucosylation was not induced in RORgtdeficient mice after S. typhimurium infection (Fig. 6C) . To investigate whether epithelial fucosylation has a role in regulating pathogenic bacterial infection, we infected wild-type or Fut2 −/− mice with S. typhimurium and examined disease progression. Compared with wild-type mice, Fut2 −/− mice were more susceptible to Salmonella infection accompanied with the observation of severe inflamed cecum (Fig. 6D) . Consistent with the inflammatory status of diseased mice, the numbers of infiltrating leukocytes in cecum were higher in Fut2 −/− mice than in wild-type mice (Fig. 6E) 1254009-7 or Fut2 −/− mice were counted 24 hours after infection (n = 5 mice per group).
*P < 0.05 by using Student's t test. NS, not significant. Three independent experiments were performed with similar results.
tissues. Collectively, these results indicate that epithelial fucosylation, regulated by Fut2, has a protective role against infection by pathogenic bacteria.
Discussion
The results of recent genome-wide association studies imply that FUT2 nonsense polymorphisms affect the incidence of various metabolic and inflammatory diseases, including chronic intestinal inflammation such as Crohn's disease and infections with pathogenic microorganisms, especially Norwalk virus and rotavirus in humans (13) (14) (15) (16) (17) (18) (19) . Understanding the mechanisms of regulation of Fut2 gene expression and fucosylation, one of the major glycosylation events in intestinal ECs, is therefore of great interest. Previously, it was thought that epithelial fucosylation is initiated by direct interaction between commensals and ECs (7). Indeed, several reports have shown that epithelial fucosylation is actively induced and used by Bacteroides (8, 9). Here, we unexpectedly found that microbiota-epithelia cross-talk is insufficient to induce epithelial fucosylation, and rather, CD90 + RORgt + ILC3 are necessary for induction of epithelial Fut2 expression and consequent fucosylation. ILC3 located in the intestinal lamina propria express high levels of IL-22 in a commensal bacteriadependent manner (Fig. 4I and fig. S7 , A and D). This IL-22 then presumably binds to IL-22R expressed by intestinal ECs, leading to the induction of Fut2 and initiation of the EC fucosylation process (Fig. 7) . In contrast to the expression of IL-22, ILC3 express LT in a commensal bacteria-independent manner. Spontaneous expression of LT on ILC3 also contributes to the induction of epithelial fucosylation. To explain the mechanism underlying induction of epithelial fucosylation, we propose that epithelial fucosylation is regulated by a two-phase system orchestrated by ILC3 through the microbiotaindependent production of LT and the induction of IL-22 by commensal bacteria (Fig. 7) . Although other types of stimulation may also affect epithelial fucosylation, our findings reveal a critical role for ILC3.
Our results demonstrated that IL-22 produced by ILC3 is necessary and sufficient for induction of epithelial fucosylation when ILC3 are appropriately stimulated by commensal microbiota (Fig. 4, A to E) . In addition to IL-22-mediated epithelial fucosylation, our results also show that the level of epithelial fucosylation is markedly reduced under LTa-deficient conditions (Fig. 5 , A to C). Our findings suggest two possibilities for the IL-22/LT-mediated regulation of epithelial fucosylation. The first is that Fut2 expression and subsequent epithelial fucosylation are induced when the intensity of synergistic or additive signals from IL-22 and LT is above the threshold for activation of Fut2. For example, LT produced by ILC3 provides the baseline signal for the minimum expression of Fut2, whereas commensalmediated IL-22 produced by ILC3 drives the maximum expression of Fut2 for the induction of epithelial fucosylation. The second possibility is that LT directly or indirectly regulates the expression of IL-22R by ECs, and vice versa, and/or the expression of IL-22. Indeed, a previous report has shown that LT produced by ILC3 regulates the expression of IL-23 by intestinal dendritic cells, as well as the subsequent production of IL-22 by ILC3 after infection with C. rodentium (45) . How ILC3-derived IL-22 and LT regulate epithelial Fut2 expression remains to be further elucidated.
Our findings provide further evidence of the critical roles of commensal microbiota, epithelial cells, and innate immune cells (such as ILC3) in the creation of a protective platform against infection by pathogenic bacteria (Fig. 7) . Ablation of epithelial fucose allowed severe infection by the pathogenic bacteria S. typhimurium (Fig. 6,  D to F) . Although the detailed mechanisms of why Fut2 −/− mice are susceptible to Salmonella infection remain unknown, one possibility is that fucosylated mucin produced by goblet cells blocks the attachment of S. typhimurium to the epithelium. Commensal microbes continuously stimulated goblet cells to release fucosylated mucin into the intestinal lumen (Fig. 2C) . Indeed, in a previous in vitro study, H-type 2 antigens, which are synthesized by Fut2 in intestinal ECs, prevented the binding of S. typhimurium to fucosylated epithelia; this supports our present findings (42) . Our findings suggest a protective role for ILC3-mediated mucus-associated fucosyl- by producing IL-22, which promotes subsequent expression of the antimicrobial molecule RegIIIg by ECs (4, 36, 45) . In addition to this, our results describe a previously unknown biological role for ILC3 in the induction and maintenance of intestinal epithelial glycosylation, which leads to the creation of an antipathogenic bacterial platform in the intestine (Fig. 7) . Furthermore, epithelial fucosylation contributes to the creation of a cohabitation niche for the establishment of normal commensal microbiota (20, 21) . Thus, ILC3-mediated control of epithelial-surface glycosylation might represent a general strategy for regulating the gut microenvironment. Targeted modification of these mechanisms has the potential to provide novel approaches for the control of intestinal infection and inflammation.
Materials and Methods Mice
C57BL/6 and BALB/c mice were purchased from CLEA Japan (Tokyo, Japan). Fut2 −/− and Il22
mice (C57BL/6 background) were generated as described previously, and Id2 −/− mice were kindly provided by Y. Yokota (33, 46, 47) . The Jackson Laboratory. Antibiotic-treated mice were fed a cocktail of broad-spectrum antibioticsnamely, ampicillin (1 g/L; Sigma, Bandai, Japan), vancomycin (500 mg/L; Shionogi, Osaka, Japan), neomycin (1 g/L; Sigma), and metronidazole (1 g/L; Sigma)-or were given these antibiotics in their drinking water, for 4 weeks as previously described (48) . These mice were maintained in the experimental animal facility at the University of Tokyo. GF and SFB or L. murinus gnotobiotic mice (BALB/c) were maintained in the GF animal facility at the Yakult Central Institute and at the University of Tokyo. In all experiments, littermates were used at 6 to 10 weeks of age.
Isolation of bacterial DNA
The isolation protocol for bacterial DNA was adapted from a previously described method (49), with some modifications. Bacterial samples in the duodenum and ileum were obtained from mice aged 8 weeks. After removal of PPs and intestinal contents, the intestinal tissues were washed three times with phosphate-buffered saline (PBS) for 10 s each time so as to collect bacteria embedded within the intestinal mucus for analysis of microbial composition. These bacteria-containing solutions were centrifuged, and the pellets were suspended in 500 mL of TE buffer (10 mM TrisHCl, 1 mM EDTA; pH 8.0). Glass beads, Trisphenol buffer, and 10% sodium dodecyl sulfate (SDS) were added to the bacterial suspensions, and the mixtures were vortexed vigorously for 10 s by using a FastPrep FP100 A (BIO 101). After incubation at 65°C for 10 min, the solutions were vortexed and incubated again at 65°C for 10 min. Bacterial DNA was then precipitated in isopropanol, pelleted by centrifugation, washed in 70%
ethanol, and resuspended in TE buffer. Extracted bacterial DNA was subjected to 16S rRNA gene clone library (50) .
16S rRNA gene clone library analyses
For 16S rRNA gene clone library analyses, bacterial 16S rRNA gene sequences were amplified by means of polymerase chain reaction (PCR) with the 27F (5′-AGAGTTTGATCCTGGCTCAG-3′) and 1492R (5′-GGTTACCTTGTTACGACTT-3′) primers. Amplified 16S rDNA was ligated into the pCR4.0 TOPO vector (Invitrogen, Carlsbad, CA), and the products of these ligation reactions were then transformed into DH-5a-competent cells (TOYOBO, Osaka, Japan). Inserts were amplified and sequenced on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA). The 27F and 520R (5′-ACCGCGGCTGCTGGC-3′) primers and a BigDye Terminator cycle sequencing kit (Applied Biosystems) were used for sequencing. Bacterial sequences were identified by means of Basic Local Alignment Search Tool (BLAST) and Ribosomal Database Project searches (50) .
Immunohistochemistry
Immunohistochemical analyses were performed as previously described, with some modifications (51). For whole-mount immunofluorescence staining, the mucus layer was removed by flushing the small intestine with PBS; then, the appropriate parts of the small intestine were fixed with 4% paraformaldehyde for 3 hours. After being washing with PBS, whole-mount tissues were stained for at least 3 hours at 4°C with 20 mg/mL UEA-1 conjugated to tetramethylrhodamine B isothiocyanate (UEA-1-TRITC; Vector Laboratories, Burlingame, CA) and 10 mg/mL wheat germ agglutinin (WGA) conjugated to Alexa Fluor 633 (Invitrogen). For whole-mount fluorescence in situ hybridization analysis, we modified the protocol previously described (52) . After fixation with 4% paraformaldehyde, intestinal tissues were washed with 1 mL PBS and 100 mL hybridization buffer (0.9 M NaCl, 20 mM Tris-HCl, 0.1% SDS) containing 2 mg EUB338 probe (5′-GCTGCCTCCCGTAGGAGT-3′) conjugated to Alexa Fluor 488 (Invitrogen). After overnight incubation at 42°C, the tissues were washed with 1 mL PBS and stained for 3 hours with 10 mg/mL WGA conjugated to Alexa Fluor 633 in PBS. After being washed with PBS, all tissues were analyzed under a confocal laser-scanning microscope (TCS SP2; Leica Microsystems, Wetzlar, Germany).
Cell preparations
A standard protocol was used to prepare intestinal ECs (53) . Tissues of the small intestine were extensively rinsed with PBS after removal of PPs. After the intestinal contents had been removed, the samples were opened longitudinally and cut into 1-cm pieces. These tissue pieces were mildly shaken in 1 mM EDTA/PBS for 10 min at 37°C. After passage through a 40-mm mesh filter, intestinal ECs were resuspended in minimum essential medium containing 20% fetal calf serum (FCS). Lamina propria (LP) cells were collected as previously described (54) 
Intracellular staining of Foxp3 and cytokines
Isolated LP cells were incubated for 4 hours at 37°C with 50 ng/mL phorbol myristate acetate (Sigma), 500 ng/mL ionomycin (Sigma), and GolgiPlug (BD Bioscience) in RPMI 1640 containing 10% FCS and penicillin and streptomycin. After incubation, cells were stained with antibodies against surface antigens for 30 min at 4°C. The cells were fixed and permeabilized with Cytofix/Cytoperm solution (BD Bioscience), and cytokines were stained with the fluorescenceconjugated cytokine antibodies. A Foxp3 staining buffer set (eBioscience) was used for intracellular staining of Foxp3.
Depletion of CD90 + ILCs
Depletion of CD90 + ILCs was performed as previously described, with some modifications (36) . Two hundred and fifty micrograms of a mAb to CD90.2 or an isotype control rat IgG2b (BioXCell, West Lebanon, NH) was given by means of intraperitoneal injection a total of three times at 3-day intervals. Intestinal ECs and LP cells were collected 2 days after the final injection.
Hydrodynamic IL-22 gene delivery system pLIVE control plasmid (Takara Bio, Shiga, Japan) or IL-22-expressing pLIVE vector (pLIVE-mIl22) was introduced into 8-week-old antibiotic-treated C57BL/6 or Rorc gfp/gfp mice. Ten micrograms per mouse of plasmid diluted in~1.5 mL TransIT-EE Hydrodynamic Delivery Solution (Mirus Bio, Madison, WI) was injected via the tail vein within 7 to 10 s. To assess IL-22 expression, serum IL-22 was quantified by means of an enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN).
Generation of PP-null mice mAb to IL-7R (A7R34) was kindly provided by S. Nishikawa. PP-null mice were generated by injecting 600 mg of mAb to IL-7R into pregnant mice on embryonic day 14 (55) .
In vivo treatment with LTbR-Ig and antibody to IL-22
Neutralization antibody to IL-22 was purchased from eBioscience. Eight-week-old Rag-deficient mice were injected intraperitoneally with antibody to IL-22 a total of five times at 3-day intervals (on days 0, 3, 6, 9, and 12). Plasmid pMKIT-expressing LTbR-Ig and LTbR-Ig treatment was performed as described previously (56) . Four-week-old C57BL/6 mice were injected intraperitoneally once a week for 3 weeks (on days 0, 7, 14, and 21) with LTbR-Ig fusion protein or control human IgG1 at a dose of 50 mg per mouse. Intestinal ECs were analyzed 3 days after the indicated injection time points. ) from C57BL/6 or Lta −/− mice and intravenously injected into irradiated recipient mice. BM chimeric mice were used for experiments 8 weeks after the BM transfer.
Adoptive transfer of mixed BM

Isolation of RNA and real-time reverse transcriptase PCR analysis
Intestinal ECs and subsets of LP cells were sorted with a FACSAria cell sorter (BD Biosciences). The sorted cells were lysed in TRIzol reagent (Invitrogen), and total RNA was extracted in accordance with the manufacturer's instructions. RNA was reverse-transcribed by using a SuperScript VILO cDNA Synthesis Kit (Invitrogen). The cDNA was subjected to real-time reverse transcriptase-PCR (rRT-PCR) by using Roche (Basel, Switzerland) universal probe/primer sets specific for Lta (primer F: 5′-tccctcagaagcacttgacc-3′, R: 5′-gagttctgcttgctggggta-3′, probe No. 62), Ltb (primer F: 5′-cctggtgaccctgttgttg-3′, R: 5′-tgctcctgagccaatgatct-3′, probe No. 76), Il22 (primer F: 5′-tttcctgaccaaactcagca-3′, R: 5′-tctggatgttctggtcgtca-3′, probe No. 17), Il22r1 (primer F: 5′;-tgctctgttatctgggctacaa-3′, R: 5′-tcaggacacgttggacgtt-3′, probe No. 9), Il10rb (primer F: 5′-attcggagtgggtcaatgtc-3′, R: 5′-gcatctcaggaggtccaatg-3′, probe No. 29), Fut2 (primer F: 5′-tgtgacttccaccatcatcc-3′, R: 5′-tctgacagggtttggagctt-3′, probe No. 67), and Gapdh (primer F: 5′-tgtccgtcgtggatctgac-3′, R: 5′-cctgcttcaccaccttcttg-3′, probe No. 80). RT-PCR analysis was performed with a Lightcycler II instrument (Roche Diagnostics) to measure the expression levels of specific genes.
Infection with S. typhimurium
Streptomycin-resistant wild-type S. typhimurium was isolated from S. typhimurium strain ATCC 14028. Fut2 −/− (BALB/c background) and control littermate mice pretreated with 20 mg of streptomycin 24 hours before infection were given 1 × 10 8 colony-forming units of the isolated S. typhimurium via oral gavage. After 24 hours, the mice were dissected, and the cecal contents were collected. Isolated cecum was treated with PBS containing 0.1 mg mL −1 gentamicin at 4°C for 30 min so as to kill bacteria on the tissue surface. The cecum was then homogenized and serial dilutions plated in order to determine the number of S. typhimurium. Sections of proximal colon were prepared 48 hours after infection. Infiltration of inflammatory cells was confirmed with hematoxylin and eosin staining.
Statistical analysis
Statistical analysis was performed with an unpaired, two-tailed Student's t-test. P values <0.05 were considered statistically significant.
